C11ORF73 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.719360E-01
Normal-vs-Stage2
9.344800E-01
Normal-vs-Stage3
9.851400E-01
Normal-vs-Stage4
4.146400E-01
Stage1-vs-Stage2
2.920800E-01
Stage1-vs-Stage3
6.655400E-01
Stage1-vs-Stage4
6.497200E-01
Stage2-vs-Stage3
9.780400E-01
Stage2-vs-Stage4
5.919400E-01
Stage3-vs-Stage4
7.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.318000E-01
Normal-vs-AfricanAmerican
8.137000E-01
Normal-vs-Asian
5.238800E-01
Caucasian-vs-AfricanAmerican
8.519600E-01
Caucasian-vs-Asian
4.422000E-01
AfricanAmerican-vs-Asian
6.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.505000E-01
Normal-vs-Female
8.569800E-01
Male-vs-Female
7.191800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.305600E-02
Normal-vs-Age(41-60Yrs)
7.275000E-01
Normal-vs-Age(61-80Yrs)
7.536200E-01
Normal-vs-Age(81-100Yrs)
7.439400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.039640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.561000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.107600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.631800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.636400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.849200E-01
Normal-vs-Daily Drinker
9.643400E-01
Normal-vs-Weekly Drinker
7.051800E-01
Normal-vs-Occasional Drinker
6.811200E-01
Normal-vs-Social Drinker
7.012600E-01
Non Drinker-vs-Daily Drinker
4.628600E-01
Non Drinker-vs-Weekly Drinker
9.138000E-01
Non Drinker-vs-Occasional Drinker
1.191790E-01
Non Drinker-vs-Social Drinker
9.463000E-01
Daily Drinker-vs-Weekly Drinker
6.007400E-01
Daily Drinker-vs-Occasional Drinker
4.383600E-01
Daily Drinker-vs-Social Drinker
5.719400E-01
Weekly Drinker-vs-Occasional Drinker
1.906030E-01
Weekly Drinker-vs-Social Drinker
9.696400E-01
Occasional Drinker-vs-Social Drinker
1.798410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.932200E-01
Normal-vs-Grade 2
8.592600E-01
Normal-vs-Grade 3
8.191600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.842100E-02
Grade 1-vs-Grade 3
5.643400E-03
Grade 1-vs-Grade 4
9.932200E-01
Grade 2-vs-Grade 3
3.375200E-01
Grade 2-vs-Grade 4
8.592600E-01
Grade 3-vs-Grade 4
8.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.718600E-01
Normal-vs-NonDiabetic
9.911200E-01
Diabetic-vs-NonDiabetic
3.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.133200E-01
Normal-vs-NoPancreatitis
8.691200E-01
Pancreatitis-vs-NoPancreatitis
3.409800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.144600E-01
Normal-vs-N1
9.294400E-01
N0-vs-N1
9.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.457900E-02
Normal-vs-TP53-NonMutant
4.481400E-03
TP53-Mutant-vs-TP53-NonMutant
1.17589999959478E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
